BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25872534)

  • 1. Orally active αvβ3 integrin inhibitor MK-0429 reduces melanoma metastasis.
    Pickarski M; Gleason A; Bednar B; Duong LT
    Oncol Rep; 2015 Jun; 33(6):2737-45. PubMed ID: 25872534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long exposure of non-cytotoxic concentrations of methylselenol suppresses the invasive potential of B16F10 melanoma.
    Kim A; Jung JY; Son M; Lee SH; Lim JS; Chung AS
    Oncol Rep; 2008 Sep; 20(3):557-65. PubMed ID: 18695906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
    Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High lung-metastatic variant of human osteosarcoma cells, selected by passage of lung metastasis in nude mice, is associated with increased expression of α(v)β(3) integrin.
    Tome Y; Kimura H; Maehara H; Sugimoto N; Bouvet M; Tsuchiya H; Kanaya F; Hoffman RM
    Anticancer Res; 2013 Sep; 33(9):3623-7. PubMed ID: 24023288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
    Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
    Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis.
    Contador-Troca M; Alvarez-Barrientos A; Barrasa E; Rico-Leo EM; Catalina-Fernández I; Menacho-Márquez M; Bustelo XR; García-Borrón JC; Gómez-Durán A; Sáenz-Santamaría J; Fernández-Salguero PM
    Carcinogenesis; 2013 Dec; 34(12):2683-93. PubMed ID: 23843039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
    Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
    Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice).
    Martínez Conesa C; Alvarez Sánchez N; Vicente Ortega V; García Reverte J; Pascual Carpe F; Campos Aranda M
    Biomed Pharmacother; 2009 May; 63(4):305-12. PubMed ID: 19171452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.
    Yacobovich S; Tuchinsky L; Kirby M; Kardash T; Agranyoni O; Nesher E; Redko B; Gellerman G; Tobi D; Gurova K; Koman I; Ashur Fabian O; Pinhasov A
    Oncotarget; 2016 Sep; 7(39):63549-63560. PubMed ID: 27556860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma.
    Bousquet PF; Paulsen LA; Fondy C; Lipski KM; Loucy KJ; Fondy TP
    Cancer Res; 1990 Mar; 50(5):1431-9. PubMed ID: 2302708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
    Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G
    Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo knockdown of CXCR4 using jetPEI/CXCR4 shRNA nanoparticles inhibits the pulmonary metastatic potential of B16‑F10 melanoma cells.
    André ND; Silva VA; Ariza CB; Watanabe MA; De Lucca FL
    Mol Med Rep; 2015 Dec; 12(6):8320-6. PubMed ID: 26498029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.
    Siveen KS; Kuttan G
    Can J Physiol Pharmacol; 2011 Oct; 89(10):691-703. PubMed ID: 21905822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
    Zhang W; Tang B; Huang Q; Hua Z
    J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone is increased in the lungs and enhances experimental lung metastasis of melanoma in DJ-1 KO mice.
    Chien CH; Lee MJ; Liou HC; Liou HH; Fu WM
    BMC Cancer; 2016 Nov; 16(1):871. PubMed ID: 27825319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
    Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anoikis induction and metastasis suppression by a new integrin αvβ3 inhibitor in human melanoma cell line M21.
    Zhang Y; Yang M; Ji Q; Fan D; Peng H; Yang C; Xiong D; Zhou Y
    Invest New Drugs; 2011 Aug; 29(4):666-73. PubMed ID: 21170668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.
    Trimmer C; Whitaker-Menezes D; Bonuccelli G; Milliman JN; Daumer KM; Aplin AE; Pestell RG; Sotgia F; Lisanti MP; Capozza F
    Cancer Res; 2010 Oct; 70(19):7489-99. PubMed ID: 20709760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.